CD3E and neoplasm: Due to the signaling capacity of the CD3ε chain, TCEs can bypass the major histocompatibility complex restriction and, independently of the epitope specificity of the TCR, elicit T-cell activation and proliferation, as well as the subsequent release of transient inflammatory cytokines induced by the TCR and trigger tumor apoptosis via perforin and granzyme release (172).